Ammonia toxicity to the brain and creatine

Area of Science:

• Neuroscience
• Biochemistry
• Toxicology

Background:

• Hyperammonemia presents age-dependent symptoms and involves complex mechanisms affecting amino acid transport and utilization.
• Brain glutamine's role in hyperammonemia is not fully understood, but altered amino acid metabolism impacts neurotransmission.
• Previous research focused on glutamine and glutamate excitotoxicity, with less attention to other metabolites like creatine.

Purpose of the Study:

• To investigate the role of creatine in ammonia toxicity during early brain development.
• To explore the impact of ammonia exposure on creatine metabolism and axonal growth in vitro.
• To determine if creatine supplementation can mitigate ammonia-induced neurotoxicity.

Main Methods:

• Utilized an in vitro model of cultured embryonic rat brain cell aggregates.
• Exposed cultures to ammonia at different developmental stages (pre-maturation vs. mature).
• Assessed creatine and phosphocreatine levels, axonal growth, and neurofilament phosphorylation using antibodies.

Main Results:

• Ammonia exposure before maturation impaired cholinergic axonal growth and decreased creatine/phosphocreatine levels.
• These effects were not observed in mature cultures.
• Creatine supplementation partially prevented axonal growth impairment, requiring glial cells for this protective effect.
• Phosphorylated intermediate neurofilament protein levels were affected by ammonia exposure.

Conclusions:

• Creatine plays a crucial role in protecting developing brain cells from ammonia toxicity.
• Impaired creatine metabolism and axonal growth are key features of early-life hyperammonemia.
• Glial cells are essential for creatine's neuroprotective effects against ammonia.
• Arginine supplementation is vital for urea cycle defect treatment due to creatine transport limitations.